The Voynich manuscript—a mysterious medieval book that has defied translation for centuries—may have been created using a special code developed with the help of cards and dice, a new study suggests.

A newly invented cipher may shed light on how the mysterious Voynich manuscript was made in medieval times. When you purchase through links on our site, we may earn an affiliate commission. Here’s how ...

Operates Bitcoin mining facilities, generating revenue primarily through the production and sale of Bitcoin. Business model centers on cryptocurrency mining operations. Cipher Mining is a U.S.-based ...

Cipher Mining Inc. (CIFR) recently entered the AI data center race with major deals with hyperscaler customers. The bitcoin miner is part of a group of companies transitioning from running data ...

The site acquisition gives Bitcoin miner Cipher a foothold in the largest US wholesale power market as miners broaden their infrastructure strategies. Cipher Mining has acquired a 200-megawatt power ...

Cipher Mining Inc (NASDAQ: CIFR) shares are gaining on Thursday. Here’s a look at what may be fueling the momentum. Cipher Mining shares are powering higher. Why are CIFR shares rallying? What To Know ...

Large language models such as ChatGPT come with filters to keep certain info from getting out. A new mathematical argument shows that systems like this can never be completely safe. Ask ChatGPT how to ...

Cipher Mining (CIFR) jumped 19% on Monday after signing a $5.5 billion lease agreement with Amazon Web Services (AWS), pushing deeper into the red-hot artificial intelligence (AI) infrastructure. The ...

Extra substitutes were supposed to help player welfare but it's not clear that has happened John Walton - PA Images Amid reports that some of Europe’s major clubs have held discussions about the ...

The Duchess of Sussex's stationery featured a regal detail Craig Barritt/Getty; Meghan Markle/Instagram Meghan Markle showed a navy notebook featuring her royal cipher on her Instagram Stories ...

Changing the FDA biosimilar interchangeability standards is a necessary but likely insufficient step to improve biosimilar competition in the US. In 2009, Congress created a regulatory pathway for ...